Brian D Gray Selected Research

Brian D Gray Research Topics

Disease

16	Neoplasms (Cancer) 03/2024 - 11/2004
3	Atherosclerosis 01/2018 - 11/2004
3	Infections 07/2012 - 04/2012
2	Necrosis 10/2023 - 04/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2016
2	Brain Neoplasms (Brain Tumor) 11/2021 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 05/2016
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2013
2	Reperfusion Injury 06/2012 - 06/2011
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2024
1	Arthritis (Polyarthritis) 03/2015
1	Colonic Neoplasms (Colon Cancer) 10/2013
1	Brain Infarction 01/2013
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2013
1	Ischemia 01/2013
1	Inflammation (Inflammations) 07/2012
1	Bacterial Infections (Bacterial Infection) 07/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2004
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 11/2004
1	Experimental Melanoma 11/2004

Drug/Important Bio-Agent (IBA)

8	PhosphatidylserinesIBA 01/2020 - 04/2012
5	Coloring Agents (Dyes)IBA 10/2021 - 01/2006
4	zinc(II) dipicolylamineIBA 11/2019 - 04/2012
3	LipidsIBA 11/2021 - 11/2004
2	Peptides (Polypeptides)IBA 01/2023 - 10/2016
2	SaposinsIBA 11/2021 - 01/2020
2	Liposomes (Liposome)IBA 11/2021 - 01/2017
2	Apolipoproteins E (ApoE)IBA 01/2018 - 01/2016
2	bis-dipicolylamine-Zinc(II)IBA 01/2017 - 07/2012
2	Messenger RNA (mRNA)IBA 11/2013 - 10/2013
1	Radioisotopes (Radionuclides)IBA 03/2024
1	177Lu-octreotateIBA 03/2024
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2024
1	Peptide Receptors (Peptide Receptor)IBA 03/2024
1	Cisplatin (Platino)FDA LinkGeneric 10/2023
1	Glucaric AcidIBA 10/2023
1	phenylalanylserineIBA 01/2023
1	prolyl-serine (Pro-Ser)IBA 01/2023
1	hydroxide ionIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Temozolomide (Temodar)FDA LinkGeneric 11/2021
1	phosphatidylethanolamineIBA 11/2019
1	compound 17IBA 11/2019
1	Annexin A5IBA 01/2018
1	duramycinIBA 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	2,2'-dipicolylamineIBA 01/2017
1	Molecular Probes (Molecular Probe)IBA 10/2016
1	Iodine-125IBA 05/2016
1	IodineIBA 05/2016
1	ApolipoproteinsIBA 01/2016
1	CollagenIBA 03/2015
1	human ERBB2 proteinIBA 11/2013
1	GuanineIBA 10/2013
1	Peptide Nucleic AcidsIBA 10/2013
1	Codon (Codons)IBA 10/2013
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2013
1	LipopolysaccharidesIBA 07/2012
1	DOTA-biotin (90Y-DOTA-biotin)IBA 07/2012
1	Biotin (Vitamin H)FDA Link 07/2012
1	technetium Tc 99m glucarateIBA 06/2012
1	Hematoxylin (Haematoxylon)IBA 06/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2012
1	Caspase 3 (Caspase-3)IBA 06/2012
1	Coordination ComplexesIBA 06/2011
1	Green Fluorescent ProteinsIBA 01/2006
1	oxidized low density lipoproteinIBA 11/2004
1	LDL Receptors (LDL Receptor)IBA 11/2004

Therapy/Procedure

5	Therapeutics 03/2024 - 11/2004
3	Aftercare (After-Treatment) 03/2024 - 11/2013
2	Drug Therapy (Chemotherapy) 10/2023 - 11/2021
1	Precision Medicine 03/2024
1	Radiotherapy 11/2021
1	Biological Therapy 01/2020
1	Intravenous Injections 01/2006